-
Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents 2-Year Clinical Outcomes: From the BIONICS and NIREUS TrialsM Konigstein, PC Smits, MP Love et al. -
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trialRV Jeger, A Farrah, MA Ohlow et al.
-
The Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk CalculatorA Khera , MJ Budoff , CJ O’Donnell et al.
-
A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With HypertriglyceridemiaKarlson BW, Palmer MK, Nicholls SJ et al.
-
Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary DiseaseM Qintar, KH Humphries, JE Park et al.
-
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trialRidker PM, MacFadyen JG, CANTOS Trial Group et al.
-
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failurePonikowski P, Voors AA, ESC Scientific Document Group. et al.
-
Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary RevascularizationH Kawashima , PW Serruys, and on behalf of the SYNTAX Extended Survival Investigators et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
